Mike Faddoul
Advertisement
An audit partner in Crowe LLP's life sciences practice with more than 33 years of experience serving public and private life sciences companies. He has extensive experience with SEC reporting, initial public offerings, internal control over financial reporting (ICFR), and other regulatory requirements. His clients range from smaller reporting companies to large accelerated filers, including companies with foreign operations.
Articles by Mike Faddoul
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
The Business Case for Employer-Based GLP-1 Coverage
5
